71
TITLE: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
AUTHORS: Ferreira, Joao Pedro ; Zannad, Faiez; Butler, Javed; Filipattos, Gerasimos; Ritter, Ivana; Schuler, Elke; Kraus, Bettina J.; Pocock, Stuart J.; Anker, Stefan D.; Packer, Milton;
PUBLISHED: 2022, SOURCE: EUROPEAN HEART JOURNAL, VOLUME: 43, ISSUE: 31
INDEXED IN: Scopus WOS CrossRef: 30
IN MY: ORCID
72
TITLE: Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial  Full Text
AUTHORS: Ferreira, JP ; Inzucchi, SE; Mattheus, M; Meinicke, T; Steubl, D; Wanner, C; Zinman, B;
PUBLISHED: 2022, SOURCE: DIABETES OBESITY & METABOLISM, VOLUME: 24, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 25
IN MY: ORCID
73
TITLE: Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
AUTHORS: Filippatos, Gerasimos; Butler, Javed; Farmakis, Dimitrios; Zannad, Faiez; Ofstad, Anne Pernille; Ferreira, Joao Pedro ; Green, Jennifer B.; Rosenstock, Julio; Schnaidt, Sven; Brueckmann, Martina; Pocock, Stuart J.; Packer, Milton; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: CIRCULATION, VOLUME: 146, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 45
IN MY: ORCID
74
TITLE: Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age  Full Text
AUTHORS: Michael Böhm; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Amr Abdin; Felix Mahfoud; Martina Brueckmann; Nicholas D Gollop; Tomoko Iwata; Piotr Ponikowski; Christoph Wanner; Faiez Zannad; Milton Packer; Stefan D Anker;
PUBLISHED: 2022, SOURCE: Journal of the American College of Cardiology, VOLUME: 80, ISSUE: 1
INDEXED IN: CrossRef: 19
IN MY: ORCID
75
TITLE: Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
AUTHORS: Subodh Verma; Nitish K Dhingra; Javed Butler; Stefan D Anker; Joao Pedro Ferreira ; Gerasimos Filippatos; James L Januzzi; Carolyn S P Lam; Naveed Sattar; Barbara Peil; Matias Nordaby; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Milton Packer; Packer M.; Anker S.; Butler J.; Filippatos G.; Pocock S.; Zannad F.; Ferreira J.P.; Brueckmann M.; George J.; Jamal W.; Welty F.K.; Palmer M.; Clayton T.; Parhofer K.G.; Pedersen T.R.; Greenberg B.; Konstam M.A.; Lees K.R.; Carson P.; Doehner W.; Miller A.; Haas M.; Pehrson S.; Komajda M.; Anand I.; Teerlink J.; Rabinstein A.; Steiner T.; Kamel H.; Tsivgoulis G.; Lewis J.; Freston J.; Kaplowitz N.; Mann J.; Petrie J.; Perrone S.; Nicholls S.; Janssens S.; Bocchi E.; Giannetti N.; Verma S.; Zhang J.; Spinar J.; Seronde M.F.; Boehm M.; Merkely B.; Chopra V.; Senni M.; Taddi S.; Tsutsui H.; Choi D.J.; Chuquiure E.; La Rocca H.P.B.; Ponikowski P.; Juanatey J.R.G.; Squire I.; Januzzi J.; Pina I.; Bernstein R.; Cheung A.; Green J.; Kaul S.; Lam C.; Lip G.; Marx N.; McCullough P.; Mehta C.; Rosenstock J.; Sattar N.; Scirica B.; Shah S.; Wanner C.; Aizenberg D.; Cartasegna L.; Colombo Berra F.; Colombo H.; Fernandez Moutin M.; Glenny J.; Alvarez Lorio C.; Anauch D.; Campos R.; Facta A.; Fernandez A.; Ahuad Guerrero R.; Lobo Márquez L.; ...More
PUBLISHED: 2022, SOURCE: LANCET DIABETES & ENDOCRINOLOGY, VOLUME: 10, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 27
IN MY: ORCID
76
TITLE: Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
AUTHORS: Butler, Javed; Filippatos, Gerasimos; Siddiqi, Tariq Jamal; Brueckmann, Martina; Bohm, Michael; Chopra, Vijay K.; Ferreira, Joao Pedro ; Januzzi, James L.; Kaul, Sanjay; Pina, Ileana L.; Ponikowski, Piotr; Shah, Sanjiv J.; Senni, Michele; Vedin, Ola; Verma, Subodh; Peil, Barbara; Pocock, Stuart J.; Zannad, Faiez; Packer, Milton; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: CIRCULATION, VOLUME: 145, ISSUE: 3
INDEXED IN: WOS CrossRef: 102
IN MY: ORCID
77
TITLE: Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
AUTHORS: Ferreira, Joao Pedro ; Vasques Novoa, Francisco ; Ferrao, Diana; Saraiva, Francisca ; Falcao Pires, Ines ; Neves, Joao Sergio ; Sharma, Abhinav; Rossignol, Patrick; Zannad, Faiez; Leite Moreira, Adelino ;
PUBLISHED: 2022, SOURCE: DIABETES CARE, VOLUME: 45, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
78
TITLE: Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind
AUTHORS: Ferreira, Joao Pedro ; Neves, Joao Sergio ;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
79
TITLE: Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial
AUTHORS: Michael Böhm; Javed Butler; Felix Mahfoud; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Jonathan Slawik; Martina Brueckmann; Bruno Linetzky; Elke Schüler; Christoph Wanner; Faiez Zannad; Milton Packer; Stefan D Anker;
PUBLISHED: 2022, SOURCE: European Journal of Heart Failure, VOLUME: 24, ISSUE: 10
INDEXED IN: CrossRef: 10
IN MY: ORCID
80
TITLE: Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced
AUTHORS: Ferreira, JP ; Anker, SD; Butler, J; Filippatos, G; Iwata, T; Salsali, A; Zeller, C; Pocock, SJ; Zannad, F; Packer, M;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 31
IN MY: ORCID
Page 8 of 32. Total results: 316.